Organogenesis Inc. (ORGO) Statistics & Valuation Metrics - Stocknear

Organogenesis Inc.

NASDAQ: ORGO · Real-Time Price · USD
4.10
-0.58 (-12.39%)
At close: Sep 26, 2025, 3:59 PM
4.15
1.22%
After-hours: Sep 26, 2025, 07:55 PM EDT

Organogenesis Statistics

Share Statistics

Organogenesis has 126.86M shares outstanding. The number of shares has increased by -4.32% in one year.

126.86M
-4.32%
0.02%
51.09%
55.47M
26,369
3.14%

Short Selling Information

The latest short interest is 10.86M, so 8.56% of the outstanding shares have been sold short.

10.86M
8.56%
24.91%
10.69

Valuation Ratios

The PE ratio is 489.38 and the forward PE ratio is 13.76. Organogenesis's PEG ratio is -5.91.

489.38
13.76
0.87
0.9
1.09
100.9
-5.91
Financial Ratio History

Enterprise Valuation

Organogenesis has an Enterprise Value (EV) of 329.1M.

0.68
20.88
23.16
78.81

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.11.

3.69
3.35
0.11
2.75
10.37
-0.83

Financial Efficiency

Return on Equity is 0.22% and Return on Invested Capital is 0.09%.

0.22%
0.17%
0.09%
$554.71K
$990.79
869
0.97
4.41

Taxes

-3.67M
130.67%

Stock Price Statistics

The stock price has increased by 41.87% in the last 52 weeks. The beta is 1.76, so Organogenesis's price volatility has been higher than the market average.

1.76
41.87%
4.75
4.08
35.4
839,679

Income Statement

In the last 12 months, Organogenesis had revenue of 482.04M and earned 861K in profits. Earnings per share was 0.01.

482.04M
366.3M
-1.28M
861K
15.76M
-1.26M
0.01
Full Income Statement

Balance Sheet

The company has 135.57M in cash and 43.31M in debt, giving a net cash position of 92.26M.

135.57M
43.31M
92.26M
-40.11M
461.13M
194.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.21M and capital expenditures -10.03M, giving a free cash flow of 4.18M.

14.21M
-10.03M
4.18M
0.03
Full Cash Flow Statement

Margins

Gross margin is 75.99%, with operating and profit margins of -0.27% and 0.18%.

75.99%
-0.27%
-0.58%
0.18%
3.27%
-0.27%
0.87%

Dividends & Yields

ORGO does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
0.2%
0.99%
Dividend Details

Analyst Forecast

The average price target for ORGO is $7, which is 70.7% higher than the current price. The consensus rating is "Buy".

$7
70.7%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

$0.03
-99.27%
0.66
-83.9%

Scores

4.63
3